Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 23, Iss. 5-6, 2017-04 ,pp. : 345-351

Karger

Access to resources Recommend Favorite

CD24 Gene Allele Variation Is Not Associated with Oligoclonal IgG Bands and IgG Index of Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 19, Iss. 3, 2012-01 ,pp. : 195-199

Karger

Access to resources Recommend Favorite

CD30 Antigen and Multiple Sclerosis: CD30, an Important Costimulatory Molecule and Marker of a Regulatory Subpopulation of Dendritic Cells, Is Involved in the Maintenance of the Physiological Balance between TH1/TH2 Immune Responses and Tolerance

By  

Neuroimmunomodulation, Vol. 12, Iss. 4, 2005-06 ,pp. : 220-234

Karger

Access to resources Recommend Favorite

Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study

By  

Neuroimmunomodulation, Vol. 20, Iss. 4, 2013-05 ,pp. : 213-222

Karger

Access to resources Recommend Favorite

Relationship between CTLA-4 and CD28 Molecule Expression on T Lymphocytes and Stimulating and Blocking Autoantibodies to the TSH-Receptor in Children with Graves’ Disease

By  

Hormone Research in Paediatrics, Vol. 64, Iss. 4, 2005-11 ,pp. : 189-197

Karger

Access to resources Recommend Favorite